Global Ulcerative Colitis Market Size, Share, Forecast Report, 2020-2027

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum part of human body. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous in these linings. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals suffering with the disease.
Segments:
Global Ulcerative Colitis Market is segmented on the basis of types and medication. Based on procedures, the market is segmented into ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Further on the basis of medication the market is classified into 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics

Key players of Global Ulcerative colitis Market:
Key players profiled in the ulcerative colitis market report are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, and Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc., Johnson & Johnson Services, Inc., Ferring B.V.